Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123880902 | 12388090 | 2 | F | 20160416 | 20160509 | 20160520 | 20160906 | EXP | ZA-LUPIN PHARMACEUTICALS INC.-2016-02013 | LUPIN | 35.95 | YR | F | Y | 0.00000 | 20160906 | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123880902 | 12388090 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG | N | UNKNOWN | 78043 | ||||||||
| 123880902 | 12388090 | 2 | C | Tareg | VALSARTAN | 1 | Unknown | 160 MG | 0 | ||||||||||
| 123880902 | 12388090 | 3 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Oral | XL8 | 0 | ||||||||||
| 123880902 | 12388090 | 4 | C | Trustan | ESOMEPRAZOLE | 1 | Oral | 40 MG | 0 | ||||||||||
| 123880902 | 12388090 | 5 | C | Oxpola 2.5 | 2 | Oral | 0.25 MG | 0 | |||||||||||
| 123880902 | 12388090 | 6 | C | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | Oral | 60 | 0 | ||||||||||
| 123880902 | 12388090 | 7 | C | One Alpha 1 | 2 | Oral | 0 | 1 | DF | Q8H | |||||||||
| 123880902 | 12388090 | 8 | C | ECOTRIN | ASPIRIN | 1 | Oral | 81 MG | 0 | ||||||||||
| 123880902 | 12388090 | 9 | C | Be-Tabs Prednisone | PREDNISONE | 1 | Oral | 5 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123880902 | 12388090 | 1 | Hypertension |
| 123880902 | 12388090 | 2 | Hypertension |
| 123880902 | 12388090 | 3 | Hypertension |
| 123880902 | 12388090 | 4 | Gastroduodenal ulcer |
| 123880902 | 12388090 | 5 | Parkinson's disease |
| 123880902 | 12388090 | 6 | Hyperparathyroidism |
| 123880902 | 12388090 | 7 | Vitamin supplementation |
| 123880902 | 12388090 | 8 | Anticoagulant therapy |
| 123880902 | 12388090 | 9 | Hypersensitivity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123880902 | 12388090 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123880902 | 12388090 | Blood glucose increased | |
| 123880902 | 12388090 | Coma | |
| 123880902 | 12388090 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123880902 | 12388090 | 1 | 2013 | 201604 | 0 | |
| 123880902 | 12388090 | 2 | 2014 | 201604 | 0 | |
| 123880902 | 12388090 | 3 | 2011 | 201604 | 0 | |
| 123880902 | 12388090 | 4 | 2011 | 201604 | 0 | |
| 123880902 | 12388090 | 5 | 2013 | 201604 | 0 | |
| 123880902 | 12388090 | 6 | 2015 | 201604 | 0 | |
| 123880902 | 12388090 | 7 | 2012 | 201604 | 0 | |
| 123880902 | 12388090 | 8 | 2012 | 201604 | 0 | |
| 123880902 | 12388090 | 9 | 2011 | 201604 | 0 |